Sinopharm: Nearly one million Chinese have been vaccinated with its Neocon vaccine

The Chinese public WeChat quoted Liu Jingzhen, Party Secretary and Chairman of the Board of Directors of China National Pharmaceutical Group, as saying that millions of people have already used the new vaccine developed by Sinoconjun, which is the world leader in research and development, clinical trials and emergency use.

He pointed out that Sinopharm is a global leader in R&D, clinical trials, production and emergency use. In terms of emergency use, nearly one million people have received Sinocrown vaccine from Sinopharm, and they have yet to receive a single report of serious adverse reaction, with only a few individuals experiencing mild symptoms.

The Chinese government approved the Xinguan vaccine for emergency use in July of this year, and people such as foreign students, government officials, and China’s foreign workers have been vaccinated with Sinopharm’s Xinguan vaccine. Critics have argued that information about China’s vaccine development has not been transparent enough, and that the emergency use of the vaccine could have serious consequences.